Fig. 5.
Fig. 5. Effect of the antagonist anti-Fas MoAb ZB4 on HLA class I–induced apoptosis. PBL were activated with PHA (5 μg/mL) for 3 days. Viable cells were pre-incubated with the antagonist anti-Fas MoAb ZB4 for 1 hour and then treated with medium, YTH862 (10 μg/mL), MoAb90 (10 μg/mL), or the agonist anti-Fas MoAb CH11 (1 μg/mL) for 20 hours. The percentage of apoptotic cells was determined by fluorescent microscopy after staining with Hoescht 33342. In parallel, inhibition of [3H]TdR uptake during the last 8 hours of culture was measured. Results are expressed as mean ± SD of four independent experiments.

Effect of the antagonist anti-Fas MoAb ZB4 on HLA class I–induced apoptosis. PBL were activated with PHA (5 μg/mL) for 3 days. Viable cells were pre-incubated with the antagonist anti-Fas MoAb ZB4 for 1 hour and then treated with medium, YTH862 (10 μg/mL), MoAb90 (10 μg/mL), or the agonist anti-Fas MoAb CH11 (1 μg/mL) for 20 hours. The percentage of apoptotic cells was determined by fluorescent microscopy after staining with Hoescht 33342. In parallel, inhibition of [3H]TdR uptake during the last 8 hours of culture was measured. Results are expressed as mean ± SD of four independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal